Steven Dayan, MD
Director, United States
Based on the research of Professor Nathan LeBrasseur, PT, PhD, the opening keynote defines biological aging and its impact on skin health, systemic function, and overall resilience, reframing aging as a modifiable process rather than an inevitable decline. By distinguishing lifespan from healthspan, the session places aesthetic medicine within a broader longevity framework focused on function, durability, and patient wellbeing. Attendees will gain insight into current and emerging, evidence-based strategies that support healthier aging and improved patient resilience within aesthetic practice and whole-patient care.
Learning Objectives:
• Define biological aging and its impact on skin health and overall function.
• Distinguish between lifespan and healthspan in the context of aesthetic and anti-aging medicine.
• Describe established and emerging strategies that support healthier aging, functional resilience, and long-term patient outcomes.
Presenter: Nathan LeBrasseur, PT, PhD.
